RE: CEPI Tweet14 Jun 2021 13:14
On a side note, great news for developing nations vaccination rates and novavax today passing phase 3 trial in the us and mexico.They've certainly come a long way.
'Novavax on Monday said a late-stage trial of its coronavirus vaccine found it was effective, an encouraging sign that there would be further doses of a medication to fight the pandemic.
Novavax said its Phase 3 trial of nearly 30,000 patients in the U.S. and Mexico found the vaccine was 90.4% effective overall and was 100% effective in protecting against moderate and severe disease.
The company said it intends to file for regulatory approval in the third quarter, and that it is on track to reach manufacturing capacity of 100 million doses by the end of the third quarter. In early June, Novavax said the trial results would be announced before the end of the month.
Novavax Chief Executive Stanley Erck told the Associated Press that many of its first doses will go to low- and middle-income countries. While more than half of the U.S. population has received at least one COVID-10 vaccine dose, less than 1% of people in the developing world have, the AP report said.'